AnalystsWilliam Pickering
William Pickering's Stock Forecasts

Analyst Ranking
Bottom 12%
#4653 out of 5263 analysts
Average Return
-3.2%
Win Rate
43%9 out of 21
Risk vs Reward
Poor
Good

William Pickering's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alnylam Pharmaceuticals IncALNY
+72.24%$235.95$406.40
2025-01-06 -
2026-01-06
Buy
Vertex Pharmaceuticals IncVRTX
+41.12%$358.40$505.78
2023-08-01 -
2024-08-01
Buy
Vertex Pharmaceuticals IncVRTX
+39.88%$354.05$495.26
2023-07-28 -
2024-07-26
Buy
Vertex Pharmaceuticals IncVRTX
+36.16%$302.66$412.11
2023-03-20 -
2024-03-20
Buy
Regeneron Pharmaceuticals IncREGN
+28.04%$586.96$751.57
2025-08-26 -
2026-04-24
Buy

William Pickering Analyst Color

Get additional color on William Pickering's coverage of popular stocks

William Pickering's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Allogene Therapeutics IncALLO
3Hold$3.85+66.67%Maintains
12 days ago
Regeneron Pharmaceuticals IncREGN
4Buy$921.00+22.54%Maintains
18 days ago
Biomarin Pharmaceutical IncBMRN
6Buy$94.00+76.76%Maintains
2 months ago
Beam Therapeutics IncBEAM
2Buy$41.00+51.24%Maintains
3 months ago
Bridgebio Pharma IncBBIO
1Buy$94.00+28.28%Initiates Coverage On
5 months ago
Biohaven LtdBHVN
3Hold$9.00-8.91%Downgrades
6 months ago
Biogen IncBIIB
1Hold$157.00-14.85%Maintains
6 months ago
Intellia Therapeutics IncNTLA
2Hold$14.50+6.38%Downgrades
6 months ago
Avidity Biosciences IncRNAM
1Hold$72.00+388.14%Downgrades
6 months ago
Sarepta Therapeutics IncSRPT
1Hold$13.00-35.96%Initiates Coverage On
9 months ago
Alnylam Pharmaceuticals IncALNY
2Buy$310.00N/AMaintains
a year ago
Arrowhead Pharmaceuticals IncARWR
2Hold$24.00N/AMaintains
a year ago
Vertex Pharmaceuticals IncVRTX
4Buy$390.00N/AMaintains
3 years ago
Crispr Therapeutics AgCRSP
1Hold$44.00N/AInitiates Coverage On
3 years ago
Ionis Pharmaceuticals IncIONS
1Sell$31.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.